Hancock Whitney’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,885
| Closed | -$201K | – | 648 |
|
|
2024
Q1 | $201K | Buy |
+5,885
| New | +$201K | 0.01% | 622 |
|
|
2023
Q2 | – | Sell |
-5,758
| Closed | -$209K | – | 661 |
|
|
2023
Q1 | $209K | Sell |
5,758
-263
| -4% | -$9.55K | 0.01% | 613 |
|
|
2022
Q4 | $214K | Sell |
6,021
-24
| -0.4% | -$853 | 0.01% | 594 |
|
|
2022
Q3 | $204K | Buy |
+6,045
| New | +$204K | 0.01% | 588 |
|
|
2022
Q2 | – | Sell |
-6,242
| Closed | -$201K | – | 674 |
|
|
2022
Q1 | $201K | Buy |
+6,242
| New | +$201K | 0.01% | 669 |
|
|
2019
Q4 | – | Sell |
-11,815
| Closed | -$325K | – | 865 |
|
|
2019
Q3 | $325K | Sell |
11,815
-1,176
| -9% | -$32.3K | 0.01% | 677 |
|
|
2019
Q2 | $430K | Buy |
12,991
+212
| +2% | +$7.02K | 0.01% | 648 |
|
|
2019
Q1 | $448K | Sell |
12,779
-7,365
| -37% | -$258K | 0.01% | 647 |
|
|
2018
Q4 | $669K | Sell |
20,144
-2,942
| -13% | -$97.7K | 0.02% | 502 |
|
|
2018
Q3 | $1.16M | Buy |
23,086
+14,615
| +173% | +$736K | 0.03% | 454 |
|
|
2018
Q2 | $507K | Buy |
+8,471
| New | +$507K | 0.02% | 426 |
|